DOI QR코드

DOI QR Code

2018-2021년 제주도 내 카바페넴내성장내세균속 균종 감염증의 역학

Epidemiology of carbapenem-resistant Enterobacteriaceae in Jeju Province, Korea, using national surveillance data, 2018-2021

  • Juyoung Park (Jeju Center for Infection Control and Prevention) ;
  • Eun-Suk Cho (Jeju Center for Infection Control and Prevention) ;
  • Jong-Myon Bae (Jeju Center for Infection Control and Prevention)
  • 투고 : 2023.01.10
  • 심사 : 2023.03.14
  • 발행 : 2023.06.30

초록

Carbapenem-resistant Enterobacteriaceae (CRE) infections have increased rapidly over the past decade and are recognized as a severe health threat in Korea and worldwide. This study aimed to identify the status and characteristics of CRE infection in Jeju province and provide important basic data for the prevention and management of CRE infection. A descriptive epidemiological analysis was performed on reported cases of CRE infection in Jeju Province between 2018 and 2021 using the integrated management system for disease, an infectious disease reporting system from the Korea Disease Control and Prevention Agency. The annual difference and distribution trends of CRE infection were analyzed using CRE isolates, carbapenemase-producing CREs (CP-CRE) and their genotypes, and the type of medical institution in Jeju Province. CRE infections steadily increased in Jeju from 2018 to 2021, and the proportion of CP-CRE among the CREs also showed a statistically significant increase each year. Among the CRE isolates, Klebsiella pneumoniae (KPC, 62.13%) was the most common, and among the CP-CRE genotypes, KPC (81.62%) showed the highest distribution and increased each year. As the distribution of CP-CRE in have increased over the past 4 years, measures to prevent the spread and outbreak of CRE infections are warranted. The results of this study are expected to be used as basic data for prevention and management of CRE infections in the province.

키워드

참고문헌

  1. Laxminarayan R. The overlooked pandemic of antimicrobial resistance. Lancet 2022;399:606-7.  https://doi.org/10.1016/S0140-6736(22)00087-3
  2. Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis 2018;66:1290-7.  https://doi.org/10.1093/cid/cix893
  3. Iovleva A, Doi Y. Carbapenem-resistant Enterobacteriaceae. Clin Lab Med 2017;37:303-15.  https://doi.org/10.1016/j.cll.2017.01.005
  4. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018;18:318-27. 
  5. Lee HJ, Lee DG. Carbapenem-resistant Enterobacteriaceae: recent updates and treatment strategies. J Korean Med Assoc 2018;61:281-9.  https://doi.org/10.5124/jkma.2018.61.4.281
  6. Kopotsa K, Osei Sekyere J, Mbelle NM. Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann N Y Acad Sci 2019;1457:61-91.  https://doi.org/10.1111/nyas.14223
  7. Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, et al. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia. Clin Infect Dis 2017;64:257-64.  https://doi.org/10.1093/cid/ciw741
  8. Go E, Joo SJ, Hwang KJ, Park S. Distributions of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2019. Public Health Weekly Report 2020;13:3353-5. 
  9. Lee E, Lee S, Yoon S, Lee Y. Number of cabapenem-resistant Enterobacteriaceae infections in the Republic of Korea (2018-2020). Public Health Weekly Report 2021;14:2770-2. 
  10. Jeong H, Hyun J, Lee Y. Characteristics of carbapenem-resistant Enterobacteriaceae (CRE) in the Republic of Korea, 2021. Public Health Weekly Report 2022;15:2360-3. 
  11. Ahn YS, Bahk HJ, Lee Y. Epidemiology of carbapenem-resistant Enterobacteriaceae in Korea between 2018 and 2019. Public Health Weekly Report 2021;14:418-20.